| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/15/2001 | DE19941897A1 New deletion mutants of Interleukin-6 receptor protein useful for production of cell proliferation inhibitors for treatment of tumors, especially multiple myeloma |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384456A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383321A1 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2382138A1 Methods and compositions for reducing immune response |
| 03/15/2001 | CA2379532A1 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | CA2376106A1 Paramyxoviruses comprising modified transcription start sequence |
| 03/14/2001 | EP1083232A1 Transfer of mRNA using polycationic compounds |
| 03/14/2001 | EP1083231A1 Smooth muscle cell promoter and uses thereof |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083227A1 Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1082463A1 Mechanical stress induced genes, expression products therefrom, and uses thereof |
| 03/14/2001 | EP1082462A1 Identification of molecular interaction sites in rna for novel drug discovery |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082445A2 Adeno-associated viral vector-mediated expression of factor viii activity |
| 03/14/2001 | EP1082444A1 Adeno-associated virus vectors and uses thereof |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082425A2 Ion channels |
| 03/14/2001 | EP1082423A1 Cyclin e2 genes and proteins |
| 03/14/2001 | EP1082419A2 Combination therapy using nucleic acids and conventional drugs |
| 03/14/2001 | EP1082418A2 Combination therapy using nucleic acids and radio therapy |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082415A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/14/2001 | EP1082412A2 Transfected cells and methods for treating diabetes |
| 03/14/2001 | EP1082410A1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082142A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082140A1 Gene expression method |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082011A2 Avian polyomavirus vaccines in psittacine birds |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0640143B1 Senescent cell derived inhibitors of dna synthesis |
| 03/14/2001 | EP0584279B1 Targeted delivery of genes encoding immunogenic proteins |
| 03/14/2001 | CN1287166A Separation, extracorporeal culture, preparation and application of human primitive mesenchymal stem cell population |
| 03/14/2001 | CA2300328A1 Modulating transcription of genes in vascular cells |
| 03/13/2001 | US6201168 Transgenic knockout mouse whose genome has homozygous disruption in endogenous beta-sarcoglycan gene; drug screening for treatments of muscular dystrophies and ischemic injuries; antiischemic agents |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201107 Cystic fibrosis gene |
| 03/13/2001 | US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6201065 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 03/13/2001 | US6200960 Inhibition of proliferation of cells |
| 03/13/2001 | US6200956 Nucleic acid-containing composition, preparation and use thereof |
| 03/13/2001 | US6200812 Sequence alterations using homologous recombination |
| 03/13/2001 | US6200811 For making human immunodeficiency virus resistant cells; gene therapy |
| 03/13/2001 | US6200807 Antisense inhibition of SHP-2 expression |
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200800 Defective moloney murine leukemia provirus used as retroviral vector for gene therapy and vaccines; has recognition sequence for elimination of proviral sequences for more accurate and safe use |
| 03/13/2001 | US6200799 Replication-defective recombinant virus includes promoter from human major intrinsic protein or human crystallin and an open reading frame of human ras, herpes simplex type i thymidine kinase, or non-phosphorylatable retinoblastoma |
| 03/13/2001 | US6200798 Defective recombinant adenoviruses with inactivated IVa2 gene |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200778 Genomic sequences for protein production and delivery |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein |
| 03/13/2001 | US6200758 Detecting a psychological disorders; obtain biopsies, detect nucleotide sequence variation, presence of variation indicates psychological disorders |
| 03/13/2001 | US6200750 Mammalian homologous recombination activating sequences and method of identification and their use thereof |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200564 Pharmaceutical compositions containing chondroitinase and uses therefor |
| 03/13/2001 | US6200560 Adeno-associated virus vectors for expression of factor VIII by target cells |
| 03/13/2001 | US6200304 Transfection system, its preparation and use in somatic gene therapy |
| 03/13/2001 | US6199554 Method and apparatus for combining injury-mediated therapy and drug delivery |
| 03/08/2001 | WO2001016379A1 Hepatitis c virus replication inhibitors |
| 03/08/2001 | WO2001016377A2 Diagnostics and therapeutics for osteoporosis |
| 03/08/2001 | WO2001016365A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016344A1 Modified adenoviral fibre and uses thereof |
| 03/08/2001 | WO2001016343A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | WO2001016341A1 Improved methods and means for retroviral gene delivery |
| 03/08/2001 | WO2001016335A2 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 03/08/2001 | WO2001016331A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 03/08/2001 | WO2001016330A2 Prevention of affections associated with porcine circovirus-2 |
| 03/08/2001 | WO2001016326A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 03/08/2001 | WO2001016324A2 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016317A2 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |